Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creon with Alternate API Source for EPI in CF or CP
NCT05069597Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- Oct 2021
- Primary completion
- Jul 2023
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pancrelipase in exocrine pancreatic insufficiency (EPI), sponsored by AbbVie Inc.. Started Oct 2021; status: completed.
02
Drugs
pancrelipase
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT05069597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05069597.